Dx Deals: Illumina to Acquire SomaLogic from Standard BioTools for $425M
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Recent inroads into testing of water for dialysis equipment illustrates Quest’s expanded scope with deals
Becton Dickinson divisions responsible for $3.4 billion in annual revenue are on the block
Quest Diagnostics will find out as it launches a new health coaching business that relies on lab testing, via its Pack Health subsidiary
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains